VERTEX PHARMACEUTICALS INC / MA Other Noncash Income (Expense)
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Other Noncash Income (Expense) of $21.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-04
- VERTEX PHARMACEUTICALS INC / MA other noncash income (expense) for the quarter ending 2026-06-30 was $16.40M.
- VERTEX PHARMACEUTICALS INC / MA other noncash income (expense) for the quarter ending 2026-03-31 was $5.00M.
- VERTEX PHARMACEUTICALS INC / MA other noncash income (expense) for the quarter ending 2025-12-31 was -$23.10M.
- VERTEX PHARMACEUTICALS INC / MA other noncash income (expense) for the quarter ending 2025-09-30 was $16.30M.
- VERTEX PHARMACEUTICALS INC / MA other noncash income (expense) for fiscal 2025 was -$113.40M.
- VERTEX PHARMACEUTICALS INC / MA other noncash income (expense) for fiscal 2024 was -$900.00K, a 102.11% decline from fiscal 2023.
- VERTEX PHARMACEUTICALS INC / MA other noncash income (expense) for fiscal 2023 was $42.60M.
- VERTEX PHARMACEUTICALS INC / MA other noncash income (expense) for fiscal 2022 was -$11.80M.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $16.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $21.40M 10-Q · filed 2026-08-04 | -$1.70M derived: sum of 3 quarters · filed 2026-08-04 | $14.60M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $5.00M 10-Q · filed 2026-05-05 | -$18.10M derived: sum of 2 quarters · filed 2026-05-05 | -$1.80M derived: sum of 3 quarters · filed 2026-05-05 | -$69.20M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | -$23.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$6.80M derived: sum of 2 quarters · filed 2026-02-13 | -$74.20M derived: sum of 3 quarters · filed 2026-08-04 | -$113.40M 10-K · filed 2026-02-13 | ||||
| 2025-09-30 | $16.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$51.10M derived: sum of 2 quarters · filed 2026-08-04 | -$90.30M 10-Q · filed 2025-11-04 | -$106.70M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | -$67.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$106.60M 10-Q · filed 2026-08-04 | -$97.00M 10-Q · filed 2025-08-05 | -$123.00M derived: sum of 3 quarters · filed 2026-08-04 | -$164.60M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-03-31 | -$39.20M 10-Q · filed 2026-05-05 | -$24.20M 10-Q · filed 2025-05-06 | -$55.60M derived: sum of 2 quarters · filed 2026-05-05 | -$97.20M derived: sum of 3 quarters · filed 2026-05-05 | -$76.50M derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | -$16.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$58.00M derived: sum of 2 quarters · filed 2026-02-13 | -$37.30M derived: sum of 3 quarters · filed 2026-02-13 | -$900.00K 10-K · filed 2026-02-13 | $56.30M 10-K · filed 2025-02-13 | |||
| 2024-09-30 | -$41.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$20.90M derived: sum of 2 quarters · filed 2025-11-04 | $15.50M 10-Q · filed 2025-11-04 | $16.20M 10-Q · filed 2024-11-05 | $48.50M derived: sum of 4 quarters · filed 2026-02-13 | |||
| 2024-06-30 | $20.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $57.10M 10-Q · filed 2025-08-05 | $57.50M 10-Q · filed 2024-08-02 | $90.10M derived: sum of 3 quarters · filed 2026-02-13 | $110.80M derived: sum of 4 quarters · filed 2026-02-13 | |||
| 2024-03-31 | $36.40M 10-Q · filed 2025-05-06 | $36.30M 10-Q · filed 2024-05-07 | $69.40M derived: sum of 2 quarters · filed 2026-02-13 | $90.10M derived: sum of 3 quarters · filed 2026-02-13 | $100.70M derived: sum of 4 quarters · filed 2026-02-13 | |||
| 2023-12-31 | $33.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $53.70M derived: sum of 2 quarters · filed 2026-02-13 | $64.30M derived: sum of 3 quarters · filed 2026-02-13 | $42.60M 10-K · filed 2026-02-13 | -$8.40M 10-K · filed 2024-02-15 | |||
| 2023-09-30 | $20.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $31.30M derived: sum of 2 quarters · filed 2024-11-05 | $9.60M 10-Q · filed 2024-11-05 | -$35.00M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | $10.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | -$11.10M 10-Q · filed 2024-08-02 | -$55.70M derived: sum of 3 quarters · filed 2025-02-13 | -$29.20M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | -$21.70M 10-Q · filed 2024-05-07 | -$66.30M derived: sum of 2 quarters · filed 2025-02-13 | -$39.80M derived: sum of 3 quarters · filed 2025-02-13 | -$28.60M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | -$44.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | -$18.10M derived: sum of 2 quarters · filed 2025-02-13 | -$6.90M derived: sum of 3 quarters · filed 2025-02-13 | -$11.80M 10-K · filed 2025-02-13 | ||||
| 2022-09-30 | $26.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $37.70M derived: sum of 2 quarters · filed 2023-11-07 | $32.80M 10-Q · filed 2023-11-07 | $38.90M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | $11.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $6.30M 10-Q · filed 2023-08-02 | $12.40M derived: sum of 3 quarters · filed 2024-02-15 | $3.10M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | -$4.90M 10-Q · filed 2023-05-02 | $1.20M derived: sum of 2 quarters · filed 2024-02-15 | -$8.10M derived: sum of 3 quarters · filed 2024-02-15 | -$17.00M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | $6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | -$3.20M derived: sum of 2 quarters · filed 2024-02-15 | -$12.10M derived: sum of 3 quarters · filed 2024-02-15 | -$14.40M 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | -$9.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | -$18.20M derived: sum of 2 quarters · filed 2022-10-28 | -$20.50M 10-Q · filed 2022-10-28 | -$20.59M 10-Q · filed 2021-11-03 | -$46.83M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2021-06-30 | -$8.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$11.20M 10-Q · filed 2022-08-05 | -$11.19M 10-Q · filed 2021-07-30 | -$37.53M derived: sum of 3 quarters · filed 2023-02-10 | -$73.59M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2021-03-31 | -$2.30M 10-Q · filed 2022-05-06 | -$2.33M 10-Q · filed 2021-04-30 | -$28.63M derived: sum of 2 quarters · filed 2023-02-10 | -$64.69M derived: sum of 3 quarters · filed 2023-02-10 | -$71.33M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2020-12-31 | -$26.33M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | -$62.39M derived: sum of 2 quarters · filed 2023-02-10 | -$69.03M derived: sum of 3 quarters · filed 2023-02-10 | -$78.70M 10-K · filed 2023-02-10 | -$78.83M 10-K · filed 2021-02-11 | |||
| 2020-09-30 | -$36.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$42.70M derived: sum of 2 quarters · filed 2021-11-03 | -$52.37M 10-Q · filed 2021-11-03 | -$73.30M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-06-30 | -$6.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | -$16.31M 10-Q · filed 2021-07-30 | -$37.23M derived: sum of 3 quarters · filed 2022-02-09 | -$27.20M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-03-31 | -$9.67M 10-Q · filed 2021-04-30 | -$30.59M derived: sum of 2 quarters · filed 2022-02-09 | -$20.56M derived: sum of 3 quarters · filed 2022-02-09 | -$29.00M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2019-12-31 | -$20.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | -$10.89M derived: sum of 2 quarters · filed 2022-02-09 | -$19.33M derived: sum of 3 quarters · filed 2022-02-09 | -$16.90M 10-K · filed 2022-02-09 | -$16.94M 10-K · filed 2020-02-13 | |||
| 2019-09-30 | $10.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $1.59M derived: sum of 2 quarters · filed 2020-10-30 | $4.02M 10-Q · filed 2020-10-30 | $12.67M 10-Q · filed 2019-10-31 | -$18.85M derived: sum of 4 quarters · filed 2021-02-11 | |||
| 2019-06-30 | -$8.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | -$6.01M 10-Q · filed 2020-07-31 | $1.04M 10-Q · filed 2019-08-01 | -$28.88M derived: sum of 3 quarters · filed 2021-02-11 | -$29.57M derived: sum of 4 quarters · filed 2021-02-11 | |||
| 2019-03-31 | $2.43M 10-Q · filed 2020-05-01 | $3.70M 10-Q · filed 2019-05-01 | -$20.45M derived: sum of 2 quarters · filed 2021-02-11 | -$21.13M derived: sum of 3 quarters · filed 2021-02-11 | -$25.32M derived: sum of 4 quarters · filed 2021-02-11 | |||
| 2018-12-31 | -$22.88M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | -$23.57M derived: sum of 2 quarters · filed 2021-02-11 | -$27.75M derived: sum of 3 quarters · filed 2021-02-11 | -$33.58M 10-K · filed 2021-02-11 | -$12.09M 10-K · filed 2019-02-13 | |||
| 2018-09-30 | -$687.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$4.87M derived: sum of 2 quarters · filed 2019-10-31 | -$10.70M 10-Q · filed 2019-10-31 | -$27.98M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | -$4.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$10.01M 10-Q · filed 2019-08-01 | -$27.29M derived: sum of 3 quarters · filed 2020-02-13 | -$29.29M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | -$5.83M 10-Q · filed 2019-05-01 | -$23.11M derived: sum of 2 quarters · filed 2020-02-13 | -$25.10M derived: sum of 3 quarters · filed 2020-02-13 | -$25.42M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | -$17.28M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$19.27M derived: sum of 2 quarters · filed 2020-02-13 | -$19.59M derived: sum of 3 quarters · filed 2020-02-13 | -$14.44M 10-K · filed 2020-02-13 | $2.80M 10-K · filed 2018-02-15 | |||
| 2017-09-30 | -$1.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | -$2.31M derived: sum of 2 quarters · filed 2018-10-25 | $2.84M 10-Q · filed 2018-10-25 | $4.79M 10-Q · filed 2017-10-30 | -$4.20M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2017-06-30 | -$318.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $4.83M 10-Q · filed 2018-07-26 | -$2.21M derived: sum of 3 quarters · filed 2019-02-13 | $2.13M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-03-31 | $5.15M 10-Q · filed 2018-04-27 | -$1.89M derived: sum of 2 quarters · filed 2019-02-13 | $2.45M derived: sum of 3 quarters · filed 2019-02-13 | -$4.82M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2016-12-31 | -$7.04M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | -$2.70M derived: sum of 2 quarters · filed 2019-02-13 | -$9.97M derived: sum of 3 quarters · filed 2019-02-13 | -$6.14M 10-K · filed 2019-02-13 | ||||
| 2016-09-30 | $4.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-30 | -$2.93M derived: sum of 2 quarters · filed 2017-10-30 | $904.00K 10-Q · filed 2017-10-30 | -$11.50M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-06-30 | -$7.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | -$3.44M 10-Q · filed 2017-07-28 | -$15.84M derived: sum of 3 quarters · filed 2018-02-15 | -$6.92M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-03-31 | $3.83M 10-Q · filed 2017-04-28 | -$8.57M derived: sum of 2 quarters · filed 2018-02-15 | $348.00K derived: sum of 3 quarters · filed 2018-02-15 | -$5.07M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2015-12-31 | -$12.41M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | -$3.49M derived: sum of 2 quarters · filed 2018-02-15 | -$8.90M derived: sum of 3 quarters · filed 2018-02-15 | -$9.53M 10-K · filed 2018-02-15 | ||||
| 2015-09-30 | $8.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $3.50M derived: sum of 2 quarters · filed 2016-10-31 | $2.88M 10-Q · filed 2016-10-31 | $2.90M 10-Q · filed 2015-10-30 | $2.88M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2015-06-30 | -$5.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | -$6.04M 10-Q · filed 2016-08-01 | -$6.04M derived: sum of 3 quarters · filed 2017-02-23 | -$6.02M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-31 | -$629.00K 10-Q · filed 2016-05-03 | -$622.00K derived: sum of 2 quarters · filed 2017-02-23 | -$607.00K derived: sum of 3 quarters · filed 2017-02-23 | -$802.00K derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $22.00K derived: sum of 2 quarters · filed 2017-02-23 | -$173.00K derived: sum of 3 quarters · filed 2017-02-23 | $0.00 10-K · filed 2017-02-23 | ||||
| 2014-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | -$180.00K derived: sum of 2 quarters · filed 2015-10-30 | -$7.00K 10-Q · filed 2015-10-30 | -$1.44M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-06-30 | -$195.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | -$22.00K 10-Q · filed 2015-08-04 | -$1.46M derived: sum of 3 quarters · filed 2016-02-16 | $691.00K derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-03-31 | $173.00K 10-Q · filed 2015-05-04 | -$1.26M derived: sum of 2 quarters · filed 2016-02-16 | $886.00K derived: sum of 3 quarters · filed 2016-02-16 | -$7.54M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2013-12-31 | -$1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-16 | $713.00K derived: sum of 2 quarters · filed 2016-02-16 | -$7.72M derived: sum of 3 quarters · filed 2016-02-16 | -$6.74M 10-K · filed 2016-02-16 | ||||
| 2013-09-30 | $2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$6.28M derived: sum of 2 quarters · filed 2014-11-06 | -$5.31M 10-Q · filed 2014-11-06 | $1.39M 10-Q · filed 2013-11-07 | -$5.79M derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2013-06-30 | -$8.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$7.46M 10-Q · filed 2014-07-31 | -$755.00K 10-Q · filed 2013-08-02 | -$7.94M derived: sum of 3 quarters · filed 2015-02-13 | -$7.50M derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2013-03-31 | $975.00K 10-Q · filed 2014-05-05 | $998.00K 10-Q · filed 2013-05-08 | $493.00K derived: sum of 2 quarters · filed 2015-02-13 | $927.00K derived: sum of 3 quarters · filed 2015-02-13 | $815.00K derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2012-12-31 | -$482.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | -$48.00K derived: sum of 2 quarters · filed 2015-02-13 | -$160.00K derived: sum of 3 quarters · filed 2015-02-13 | -$178.00K 10-K · filed 2015-02-13 | $212.00K 10-K · filed 2013-03-01 | |||
| 2012-09-30 | $434.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $322.00K derived: sum of 2 quarters · filed 2013-11-07 | $304.00K 10-Q · filed 2013-11-07 | $350.00K 10-Q · filed 2012-11-06 | -$1.00K derived: sum of 4 quarters · filed 2014-02-11 | |||
| 2012-06-30 | -$112.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | -$130.00K 10-Q · filed 2013-08-02 | -$435.00K derived: sum of 3 quarters · filed 2014-02-11 | -$672.00K derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2012-03-31 | -$18.00K 10-Q · filed 2013-05-08 | -$323.00K derived: sum of 2 quarters · filed 2014-02-11 | -$560.00K derived: sum of 3 quarters · filed 2014-02-11 | -$541.00K derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2011-12-31 | -$305.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11 | -$542.00K derived: sum of 2 quarters · filed 2014-02-11 | -$523.00K derived: sum of 3 quarters · filed 2014-02-11 | -$319.00K 10-K · filed 2014-02-11 | -$264.00K 10-K · filed 2012-02-22 | |||
| 2011-09-30 | -$237.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | -$218.00K derived: sum of 2 quarters · filed 2012-11-06 | -$14.00K 10-Q · filed 2012-11-06 | -$224.00K derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $223.00K 10-Q · filed 2012-08-08 | $13.00K derived: sum of 3 quarters · filed 2013-03-01 | |||||
| 2011-03-31 | $204.00K 10-Q · filed 2012-05-10 | -$6.00K derived: sum of 2 quarters · filed 2013-03-01 | ||||||
| 2010-12-31 | -$210.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $31.00K 10-K · filed 2013-03-01 | ||||||
| 2010-09-30 | $241.00K 10-Q · filed 2011-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |